Effect of APG on liver function indices
ALT and AST are enzymes mainly confined within the hepatocytes, although they are also found in the heart, kidney, blood cells and pancreas
(Aja et al., 2020) while monoamine oxidase is a mitochondrial enzyme with high activity in the brain, GIT and hepatic tissue
(Jaka et al., 2021). CCl
4 significantly increased the serum activities of ALT, AST and MAO compared to normal control. However, the administration of APG prevented these toxic effects in a dose-dependent mannerreduction (Table 1).
Similar result was obtained by
Liu et al., (2018) and
Almatroodi et al., (2020). Elevations in activities of ALT and AST is due to cellular leakage and loss of functional integrity of hepatic cell membrane, where as elevated ALP activity is a marker of hepatic-cholestatic damage while increased hepatic MAO activity reveals mitochondrial injury
(Abou Seif, 2016). Furthermore, hepatic necrosis which was observed in our histopathological analysis has been implicated as a contributory factor to ALT and AST release into the blood circulation. Contrarily, concomitant administration of APG (10 and 20 mg/kg body weight) to rats inhibited CCl
4-mediated hepatic damage dose-dependently in this study. This result agree with that study of
Yue et al., (2020).
Effect of APG on oxidative stress markers
It is known that SOD, CAT and GPx are cellular antioxidant enzymes that scavenge ROS and thus promote antioxidant mechanism. CCl
4 sigmificantly reduced the activities of SOD, CAT and GPx and increased MDA level.
However, the administration of APG (at 10 and 20 mg/kg body weight) significantly increased the activities of these enzymes and decreased MDA level compared to CCl
4 group. APG exerted significant dose-dependent reduction on MDA alone (Table 2). These findings can be confirm by previous reports
(Ubhenin et al., 2016). The significant depression in the hepatic activities of SOD, CAT and GPx implies the overwhelming oxidative imbalance exerted by the CCl
4 metabolites leading to antioxidant imbalance and/or oxidative stress in the rat liver exposed to CCl
4.
The chief mechanism underlying CCl
4 hepatotoxicity is oxidative stress arising from the hepatic metabolites of CCl
4 (trichloromethyl and trichloromethyl peroxyl radicals). These hepatic metabolites, are ROS generators and consumers of antioxidant balance
(El-Hadary and Hassanien, 2016). Intriguingly, trichloromethyl can react with sulfhydryl groups present in glutathione, GPx and protein thiols to form an oxidative complex, exerting deleterious effects on SOD and CAT
(El-Hadary and Hassanien, 2016).
Interestingly, the APG administration scavenged the ROS and enhanced hepatic antioxidant homeostasis. This was evident through prominently elevated hepatic activities of SOD, CAT and GPx and decreased level of MDA compared to CCl
4 group, in consonance with earlier studies
(Raskovic et al., 2017 and
Ubhenin et al., 2016). Consequently, appreciably indicating ability of APG to inhibit oxidative stress.
It was noteworthy to observe that the two doses of APG failed to demonstrate dose-dependent increases in SOD, CAT and GPx activities but only in MDA level (Table 2). A robust body of literature indicates APG antioxidant property
(DeRango-Adem and Blay, 2021). It is a natural polyphenolic flavonoid flavone with ROS-scavenging activity and other pharmacological properties
(Salehi et al., 2014). By implication, therefore, APG demonstrates a hepatoprotective effect against CCl4 oxidative stress
via its antioxidant property. The free hydroxyl groups present on the A/B rings of APG are responsible for the antioxidant effects of this flavone
(Singh et al., 2014).
Effect of APG on inflammatory markers in CCl4-intoxicated rats
In CCl
4 group, the levels of IL-6 and TNF-α significantly increased while the levels of anti-inflammatory markers, IL-4 and IL-10 is significantly reduced compared to normal control. This result indicates that CCl4 provokes pro-inflammation and depresses anti-inflammation
(Yang et al., 2018). The oxidative stress observed herein might have enhanced the induction of cytokine expression. Oxidative stress status may trigger the nuclear translocation of nuclear factor-kappa B (NF-κB) to stimulate the expression of cytokine proteins
Edeogu et al., (2020), which has been reported to occur during CCl
4 hepatotoxicity
(Tsai et al., 2017).
However, APG administration prominently abrogated the effect of CCl
4 on these cytokines. Interestingly, the two doses of APG expressed a dose-dependent effect on IL-6 and TNF-α only (Table 3). Accumulating number of studies demonstrate that APG can suppresses inflammatory cascades
(Salehi et al., 2019).
Effect of APG on apoptosis markers in CCl4-intoxicated rats
Serum levels of M30 and M65 are indicator of apoptosis of cells undergoing necrosis and cell death de Haas
et al. (2008). The release of TNF-α promotes cell apoptosis leading to hepatocyte cell death
(Li et al., 2020). The CCl
4 significantly increased the level of M65 and M30 in comparison to the normal control (Fig 1). The induction of apoptosis by CCl
4 in this study corroborate the findings of previous studies
(Li et al., 2020).
On the contrary, the APG doses significantly reduced the levels of M65 and M30 compared to CCl
4 group (Fig 1). Interestingly, the two doses of APG revealed a dose-dependent effect on M65 and M30, respectively.
Also, there was dose-dependent antiapoptotic effects of APG as mentioned in previous studies
(Mohamed et al., 2020 and
Zhong et al., 2017).
Histopathological analysis
Fig 2 showed that, the control group (1a), the liver architecture appears normal with hepatocytes, blood sinusoids and central vein. On the contrary, the liver histological analysis from CCl
4 group revealed inflammatory cells infiltration (star), cytoplasmic vacuolation and degeneration and severe hepatic necrosis (arrow) (2a). The oxidative milieu created by CCl
4 may be the cause of these histopathologic lesions. The observed infiltration of inflammatory cells in our histopathological analysis could also account for the increased IL-6 and TNF-α levels in this study
(Yeh et al., 2013).
The administration of APG in the APG + CCl4 groups ameliorated the CCl
4-induced alterations to mild lesions (3a and 4a). The APG only did not alter the liver structures (5a and 6a).